Antisense Therapeutics Limited (ATHJF) Stock Analysis
DELISTED
What happened to Antisense Therapeutics Limited (ATHJF) stock?
Antisense Therapeutics Limited (ATHJF) no longer trades on public markets. The figures below are historical and are not a current quote.
- Status:
- Delisted — no longer trades
Market cap $19.6M is the value of all shares combined.
For informational purposes only. Not financial advice. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR
Antisense Therapeutics Limited (ATHJF). Antisense Therapeutics Limited is an Australian biopharmaceutical company focused on the research and development of novel antisense pharmaceuticals.
Last analyzed: Jun 14, 2026Dated analysis: the newest financial statements on file are 28 months old (Jun 1, 2024), so the figures and score below describe that period, not today.
Antisense Therapeutics Limited (ATHJF) Healthcare & Pipeline Overview
ATHJF OTC Market Information
ATHJF trades on the OTC Other market tier of OTC Markets.
- OTC Tier: OTC Other
More about this archive record
Can I still buy ATHJF shares?
No. ATHJF stopped trading on public markets, so the shares are not available through a broker. Anything you see quoted for ATHJF elsewhere is historical data, not a live market.
Are the figures on this page current?
No. Every number here is the last value recorded before ATHJF stopped trading. Nothing on this page updates, and none of it is a current quote.
Why does this page still exist?
Because people still search for what happened to Antisense Therapeutics Limited. An archived profile that states the delisting plainly is more useful than a dead link — provided it is labelled as history, which is what this page does.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.